ORMP Stock Analysis: Buy, Sell, or Hold?
ORMP - Oramed Pharmaceuticals Inc.
$4.01
0.13 (3.35%)
▲
5d:
+3.62%
30d:
-6.31%
90d:
+14.9%
BUY
HIGH Confidence
Analysis Updated: Jun 22, 2026 12:00 AM ET
Earnings: Aug 13, 2026
Get Alerted When ORMP Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: ORMP shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
✅ BUY SIGNAL: ORMP shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
In-depth Analysis How we analyze
Valuation Analysis: ORMP is currently trading at $4.01, which is considered fair relative to its 30-day fair value range of $3.67 to $4.27.
Technical Outlook: Technically, ORMP is in a uptrend. Immediate support is located at $3.58, while resistance sits at $4.14. The stock is showing strong short-term momentum, up 3.4% recently.
Market Sentiment: ORMP has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $6.25 (+55.9%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, ORMP is in a uptrend. Immediate support is located at $3.58, while resistance sits at $4.14. The stock is showing strong short-term momentum, up 3.4% recently.
Market Sentiment: ORMP has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $6.25 (+55.9%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$3.67 -
$4.27
Company Quality Score
53/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
92.1%
All Signals
- NEUTRAL: Price in fair range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+3.4%)
- BULLISH: Trading 55.9% below Wall St target ($6.25)
Trading Range Analysis
30-Day Trading Range
$3.67 -
$4.27
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$3.58
Resistance Level
$4.14
Current Trend
Uptrend
Technical data as of
Jun 9, 2026
Fundamental Context
Wall Street Target
$6.25
(+55.9%)
Revenue Growth (YoY)
-100.0%
Earnings Growth (YoY)
40.9%
Share & Embed Analysis
Last updated: June 22, 2026 11:46 PM ET
Data refreshes hourly during market hours. Next update: 12:46 AM
Data refreshes hourly during market hours. Next update: 12:46 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ORMP showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$27 | 56 HOLD |
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1022 | 64 BUY |
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$412 | 53 HOLD |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 57 HOLD |
|
RCKT
Rocket Pharmaceuticals I… |
STRONG BUY
18 analysts |
$9 | 59 HOLD |
